Using Synthetic Glycans to Investigate Anti-Glycan Antibodies and Explore Their Medical Potential. [PDF]
Weber F +4 more
europepmc +1 more source
Cancer-associated alterations in O-GalNAc glycosylation. [PDF]
Pires J +4 more
europepmc +1 more source
High Expression of SSEA3 and Globo H Predicts Poor Outcomes in Resected Extrahepatic Cholangiocarcinoma: A Single-Center Retrospective Cohort Study. [PDF]
Hung TH +6 more
europepmc +1 more source
From Lock-and-Key to Velcro: Glycan-Dependent T Cell Recruiter Redefines Cancer Cell Targeting With Density-Dependent Recognition. [PDF]
Wei P, Tong A, Zhao L.
europepmc +1 more source
From Glycocode to Precision Oncology: Therapeutic Strategies Targeting Aberrant O-GalNAc Glycosylation in Cancer. [PDF]
Aasted MKM +5 more
europepmc +1 more source
Erythrocyte-inspired biomaterials for cancer immunotherapy: Integration within the cancer-immunity cycle. [PDF]
Javadi P, Azadi A.
europepmc +1 more source
Advances in Exercise-Mediated Regulation of the Gut Microbiota via the Muscle-Gut Axis: Implications for Tumor Immunity and Treatment Responses. [PDF]
Pang T, Zhou X, Ge Z.
europepmc +1 more source
Mucin dysregulation in salivary gland tumorigenesis: Diagnostic, prognostic, and therapeutic insights: A systematic review & meta-analysis. [PDF]
Chatterjee S +4 more
europepmc +1 more source
Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II. [PDF]
Schambach A, Martin F, Maccalli C.
europepmc +1 more source
Studies on a Sulfoxide-Bridged Tn Antigen Mimetic: Interaction with Macrophage Galactose Lectin and Inhibition of Sialyltransferase ST6GALNAC1. [PDF]
Sodini A +8 more
europepmc +1 more source

